Breast cancer drug receives 'breakthr...

Breast cancer drug receives 'breakthrough therapy' designation from FDA

There are 1 comment on the Holtville Tribune story from Apr 14, 2013, titled Breast cancer drug receives 'breakthrough therapy' designation from FDA. In it, Holtville Tribune reports that:

An experimental drug being investigated for the treatment of advanced breast cancer by researchers from the Revlon/UCLA Women's Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center this week received "breakthrough therapy" designation from the U.S. Food and Drug Administration.

Join the discussion below, or Read more at Holtville Tribune.

Since: Feb 10

Saint Petersburg, FL

#1 Apr 14, 2013
Wow. 24 1/2 months compared to 4 1/2 months -- that's finally some real progress. In 24 months you might live to see your first grandchild born, or your youngest graduate from college. Does it matter to you? In the moment, yes, but it matters to that child for the rest of his or her life.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News Psychological intervention reduces fear of recu... Jun 6 Humanspirit 1
News Vaccine may cut HPV infections, an oral cancer ... May '17 HPV conjob 1
News Parker Hughes Cancer center suspending operations (Feb '08) Apr '17 Laura 17
Benign tumor Mar '17 Bharath k 1
News Myriad Genetics Announces an Assay that Identif... (Nov '16) Feb '17 Purplemouse2 8
News Holzer receives donation from Fruth pharmacies Jan '17 Steve 1
News New team players: Palliative care specialists f... Jan '17 Death 3
More from around the web